300705: Hunan Jiudian Pharmaceutical Co., Ltd. - Summary | Jitta

Hunan Jiudian Pharmaceutical Co., Ltd.

CHN:300705

Price
CN¥12.62
Loss Chance
43.5%
5.93JITTA SCORE
28.14%Under Jitta Line
Jitta Ranking
262 / 486
2,579 / 5,270
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (39)
Recent Business Performance (22)
Financial Strength (89)
Return to Shareholders (71)
Competitive Advantage (54)
Jitta Signs
Revenue and EarningConsistent High Growth in the past 5 years
Debt LevelLow Long Term Debt
Dividend PayoutIncreasing Every Year
Interest Coverage RatioVery Good
SG&A to SalesDecreasing
Recent Business PerformanceEarning decline 53.59% in the last quarter (yoy)
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
5.93
28.14%
4.40
> 1,000%
4.23
> 1,000%
Pharmaceuticals
7.55
2.58%
5.63
16.32%
7.34
27.35%
COMPANY DESCRIPTION
Hunan Jiudian Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. The company offers chemical drug preparations, active pharmaceutical ingredients (APIs), pharmaceutical excipients, traditional Chinese medicine, health foods, and rehabilitation and wellness products. Its products portfolio includes loxoprofen sodium gel patches, ketoprofen gel patches, pantopril sodium enteric-coated tablets, dapagliflozin tablets, and rosuvastatin calcium. It also provides digestive system and metabolic, nervous system, cardiovascular system medications, musculoskeletal, anti-infective, respiratory system medications, blood and hematopoietic system, and reproductive and urinary system and hormone drugs. In addition, the company offers CMO/CDMO; software development and technical; and pharmaceutical retail services. Hunan Jiudian Pharmaceutical Co., Ltd. was founded in 2001 and is based in Changsha, China.